{"id":5159,"date":"2016-07-15T14:00:12","date_gmt":"2016-07-15T21:00:12","guid":{"rendered":"https:\/\/www.everywomanover29.com\/blog\/?p=5159"},"modified":"2016-07-15T08:14:11","modified_gmt":"2016-07-15T15:14:11","slug":"gaba-consuming-bacteria-discovered-evtepia-gabavorous","status":"publish","type":"post","link":"https:\/\/www.everywomanover29.com\/blog\/gaba-consuming-bacteria-discovered-evtepia-gabavorous\/","title":{"rendered":"GABA-consuming bacteria discovered: Evtepia gabavorous"},"content":{"rendered":"

\"bacteria\"<\/p>\n

New bacteria that consumes GABA, the main calming neurotransmitter, has been discovered. It has provisionally been named KLE1738 Evtepia gabavorous <\/em>(vorous means \u201ceating\u201d).<\/p>\n

This new discovery was presented at the recent American Society for Microbiology<\/a>\u00a0conference in Boston in the Microbial Mind Control session<\/a>.<\/p>\n

Here is the entire abstract:\u00a0Gaba Modulating Bacteria of the Human Gut Microbiome<\/a>:<\/p>\n

\n

The gut microbiome affects many different diseases, and has been recently linked to human mental health. The microbiome community is diverse, but 50-80% of its diversity remains uncultured. We previously reported that uncultured bacteria from the marine environment require growth factors from neighboring species, and by using co-culture, we could cultivate novel diversity. In the present study, we used a similar co-culture approach to grow bacteria from humans stool samples. KLE1738, a \u201cMost-Wanted\u201d member of the human gut microbiome only known by its 16S rDNA signature, was found to require the presence of Bacteroides fragilis<\/strong> KLE1758 for growth. Using bio-assay driven purification of B. fragilis<\/strong> KLE1758 supernatant, \u03b3-aminobutyric acid (GABA), the major inhibitory neurotransmitter of the central nervous system, was identified as the growth factor for KLE1738. We found no other tested compound but GABA supported the growth of KLE1738, and genomic analysis suggests an unusual metabolism focused on consuming GABA. Due to this unique growth requirement, we provisionally name KLE1738 Evtepia gabavorous<\/strong>. Using growth of E. gabalyticus<\/strong> as an indicator, we then identified novel GABA producing bacteria from the gut microbiome. Reduced levels of GABA are associated with depression, and we found fewer GABA producers in a human cohort of depressed individuals. By modulating the level of GABA, microbial producers and consumers of this neurotransmitter may be influencing host behavior.<\/p>\n<\/blockquote>\n

If you\u2019re anxious and especially if you have physical anxiety, it\u2019s worth considering if low GABA is an issue and addressing your anxiety by trying to raise your GABA levels by taking GABA as a supplement<\/a>, with lifestyle activities like yoga sessions<\/a>, by eating a real whole foods traditional diet<\/a>\u00a0and by addressing gut health.<\/p>\n

There is much research supporting the gut-brain connection and how imbalances of the microbiome i.e. intestinal dysbiosis, can contribute to:<\/p>\n